Source:http://linkedlifedata.com/resource/pubmed/id/17532039
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
25
|
pubmed:dateCreated |
2007-6-8
|
pubmed:abstractText |
Sodium salts of D-3-hydroxybutyrate (D-3-HB), DL-3-hydroxybutyrate (DL-3-HB) and methyl (D)-3-hydroxybutyrate (M-3-HB), are derivatives of 3-hydroxybutyric acid (3-HB), a ketone body that is produced in vivo in animals including human. D-3-HB is the most common degradation product of microbial polyhydroxyalkanoates (PHA) that have been investigated for tissue engineering application. This study evaluated the in vitro effect of PHA degradation product 3-HB and its derivatives (collectively called 3-HB derivatives) on cell apoptosis and cytosolic Ca(2+) concentration of mouse glial cells. Results showed that the percentage of cells undergoing apoptosis decreased significantly in the presence of 3-HB and its derivatives as evidenced by flow cytometry. The in vitro study on cytosolic Ca(2+) concentration demonstrated that 3-HB derivatives dramatically elevated the cytosolic Ca(2+) concentration. Both the extracellular and intracellular Ca(2+) contributed as the sources of such Ca(2+) concentration elevation. The effect of 3-HB derivatives on cytosolic Ca(2+) concentration could be reduced by nitredipine, an L-type voltage-dependent calcium channel antagonist. In comparison, M-3-HB worked more efficiently than D-3-HB and DL-3-HB did as M-3-HB is more efficient in permeation into the cells. All results indicated that 3-HB derivatives had an inhibitory effect on cell apoptosis which is mediated by signaling pathways related to the elevation of cytosolic Ca(2+) concentration. This positive effect helps explain the biocompatibility observed for PHA, it also points to the possibility of 3-HB derivatives regardless of chirality to become an effective neural protective agent.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0142-9612
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3608-16
|
pubmed:meshHeading |
pubmed-meshheading:17532039-3-Hydroxybutyric Acid,
pubmed-meshheading:17532039-Animals,
pubmed-meshheading:17532039-Apoptosis,
pubmed-meshheading:17532039-Calcium,
pubmed-meshheading:17532039-Cell Proliferation,
pubmed-meshheading:17532039-Cell Survival,
pubmed-meshheading:17532039-Cells, Cultured,
pubmed-meshheading:17532039-Cytosol,
pubmed-meshheading:17532039-Dose-Response Relationship, Drug,
pubmed-meshheading:17532039-Flow Cytometry,
pubmed-meshheading:17532039-Mice,
pubmed-meshheading:17532039-Mice, Inbred BALB C,
pubmed-meshheading:17532039-Neuroglia,
pubmed-meshheading:17532039-Neuroprotective Agents
|
pubmed:year |
2007
|
pubmed:articleTitle |
The effect of 3-hydroxybutyrate and its derivatives on the growth of glial cells.
|
pubmed:affiliation |
Multidisciplinary Research Center, Shantou University, Shantou 515063, Guangdong, China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|